Ralph Schutz works in the field of Emergency Medicine. He went to University of Kansas School of Medicine. Ralph Schutz is a published doctor as well. He has 1 publication published. The latest was: Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist.
![]() |
Dr. Raina L. Shanks, DO |
![]() |
Dr. John D. McEnroe Jr., MD
![]() |
![]() |
Dr. Kevin J. Koch, MD
![]() |
![]() |
Dr. Lester E. Richardson, DO
![]() |
![]() |
Dr. Erik J. Stamper, DO
![]() |
![]() |
Dr. Denise K. Miller, MD |
![]() |
Dr. David R. Gustafson, DO |
![]() |
Dr. Robert L. Schoenen II, DO
![]() |